News & Press Releases
Filter by:
Republicans Seek Probe Into EpiPen's Medicaid Rebate Status
September 13, 2016
Ellyn Sternfield, a Mintz Special Counsel, is quoted in this Bloomberg BNA Health Care Daily Report article on claims by congressional Republicans that Medicaid’s classification of EpiPens as “generic” lowered company rebates paid to the program.
Immigrant Investor Program Changes Pushed in Congress as Deadline Looms
September 13, 2016
Mintz Corporate & Securities and Immigration Member Doug Hauer is quoted in this Bloomberg BNA Daily Labor Report article covering efforts to push changes to the EB-5 visa program in Congress as its reauthorization deadline approaches.
Mintz Member Adam L. Sisitsky Named Co-Chair of Firm’s Securities Litigation Practice
September 12, 2016
Mintz has named Adam L. Sisitsky Co-Chair of the firm’s Securities Litigation Practice. Mr. Sisitsky will serve along with current Co-Chair, John F. Sylvia.
Six Mintz Members to Speak at 2016 IBA Annual Conference
September 12, 2016
Six Mintz Members will speak at the 2016 International Bar Association Conference. The Members are Robert I. Bodian, Richard R. Kelly, Heidi A. Lawson, Bruce D. Sokler, Stephen M. Weiner, and Laura Bange Stephens.
Mintz Achieves Denial of Class Certification for adidas America Inc.
September 09, 2016
Mintz attorneys successfully represented adidas America Inc. in arguing against certification of a class action suit involving one of the company’s popular running shoes. The U.S. District Judge ruled the plaintiff did not present sufficient evidence that adidas’ Springblade shoes were defective.
Mintz Represents Myriad Genetics in Acquisition of Assurex Health
September 08, 2016
Attorneys from Mintz represented Myriad Genetics, Inc. in its acquisition of Assurex Health, an informatics-based precision medicine company providing treatment decision support to health care providers for mental health patients.
